Literature DB >> 23289635

CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis.

Jie Liu1, Hong-Xin Zhang.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the SNPs +49A/G and CT60A/G of the CTLA-4 gene are associated with susceptibility to systemic lupus erythematosus (SLE).
METHODS: The comprehensive meta-analysis for +49A/G included 1753 cases and 2279 controls, and for CT60A/G included 676 cases and 576 controls. Allelic and genotypic comparisons between cases and controls were evaluated. For +49A/G, we also subdivided it by population.
RESULTS: For +49A/G, statistically significant differences were not noted (fixed: odds ratio [OR]: 1.033, 95% confidence interval [95% CI]: 0.937-1.139; random: OR: 1.038, 95% CI: 0.907-1.188). When subdivided into Asia and Europe subgroups, it showed that this polymorphism is still not significantly associated with SLE [for Asia: (fixed: OR: 1.069, 95% CI: 0.932-1.227; random: OR: 1.055, 95% CI: 0.846-1.316); for Europe: (fixed: OR: 0.988, 95% CI: 0.842-1.161; random: OR: 1.015, 95% CI: 0.805-1.281)]. And CT60A/G also did not demonstrate significant differences with SLE (fixed: OR: 1.099, 95% CI: 0.922-1.31; random: OR: 0.918, 95% CI: 0.581-1.448).
CONCLUSION: The results suggest that the CLTA-4 gene was not associated with SLE. Further investigations are required to identify whether other at-risk polymorphisms within CTLA-4 confer a risk of SLE and to clarify the role of the CTLA-4 gene.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23289635      PMCID: PMC3582276          DOI: 10.1089/gtmb.2012.0302

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  40 in total

1.  SLEN2 (2q34-35) and SLEN1 (10q22.3) replication in systemic lupus erythematosus stratified by nephritis.

Authors:  Ana I Quintero-del-Rio; Jennifer A Kelly; C Phillip Garriott; David C Hutchings; Summer G Frank; Christopher E Aston; John B Harley
Journal:  Am J Hum Genet       Date:  2004-08       Impact factor: 11.025

2.  Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.

Authors:  Ingorn Kimkong; Jeerawat Nakkuntod; Siriwalee Sae-Ngow; Thiti Snabboon; Yingyos Avihingsanon; Nattiya Hirankarn
Journal:  Asian Pac J Allergy Immunol       Date:  2011-09       Impact factor: 2.310

3.  CTLA4 mediates antigen-specific apoptosis of human T cells.

Authors:  J G Gribben; G J Freeman; V A Boussiotis; P Rennert; C L Jellis; E Greenfield; M Barber; V A Restivo; X Ke; G S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

4.  Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus.

Authors:  Belén Torres; Francisco Aguilar; Ernesto Franco; Elena Sánchez; Julio Sánchez-Román; Juan Jiménez Alonso; Antonio Núñez-Roldán; Javier Martín; María Francisca González-Escribano
Journal:  Arthritis Rheum       Date:  2004-07

5.  Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.

Authors:  Marta Barreto; Eugénia Santos; Ricardo Ferreira; Constantin Fesel; Maria Francisca Fontes; Clara Pereira; Berta Martins; Rita Andreia; João Faro Viana; Francisco Crespo; Carlos Vasconcelos; Carlos Ferreira; Astrid Moura Vicente
Journal:  Eur J Hum Genet       Date:  2004-08       Impact factor: 4.246

6.  A revised estimate of twin concordance in systemic lupus erythematosus.

Authors:  D Deapen; A Escalante; L Weinrib; D Horwitz; B Bachman; P Roy-Burman; A Walker; T M Mack
Journal:  Arthritis Rheum       Date:  1992-03

7.  Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes.

Authors:  M P Bettinotti; K Hartung; H Deicher; G Messer; E Keller; E H Weiss; E D Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

8.  A new member of the immunoglobulin superfamily--CTLA-4.

Authors:  J F Brunet; F Denizot; M F Luciani; M Roux-Dosseto; M Suzan; M G Mattei; P Golstein
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

9.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  Treatment of murine lupus with CTLA4Ig.

Authors:  B K Finck; P S Linsley; D Wofsy
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

View more
  4 in total

1.  Role of CD152 genetic polymorphisms in the susceptibility to breast cancer.

Authors:  Hai Chen; Xiaodong Qi; Xue Bai; Ping Qiu; Bin Chen
Journal:  Oncotarget       Date:  2017-04-18

2.  Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset.

Authors:  Sophie Steiner; Sonya C Becker; Jelka Hartwig; Franziska Sotzny; Sebastian Lorenz; Sandra Bauer; Madlen Löbel; Anna B Stittrich; Patricia Grabowski; Carmen Scheibenbogen
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

Review 3.  Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.

Authors:  Damilola Oyewole-Said; Vanaja Konduri; Jonathan Vazquez-Perez; Scott A Weldon; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

4.  Effects of Peptide-Induced Immune Tolerance on Murine Lupus.

Authors:  Ram P Singh; Bevra H Hahn; David S Bischoff
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.